Navigation Links
DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels
Date:10/2/2008

DuPont BioFuels Leader Provides Business Update to Investors

WILMINGTON, Del., Oct. 2 /PRNewswire-FirstCall/ -- Speaking today at an investor conference, DuPont Vice President & General Manager John Ranieri said the company's plans to bring its two advanced biofuels programs to market are on track and making significant technical progress toward the commercialization of biobutanol and the conversion of cellulosic feedstocks economically into biofuels.

"Biobutanol and cellulosic ethanol have the ability to transform the biofuels industry," Ranieri said. "Our flexible business models allow us to penetrate different geographies with the ability to convert various feedstocks to meet the significant global demand for biofuels."

The DuPont BioFuels business strategy is developing and commercializing an upstream biofuel technology to produce cellulosic ethanol that will use non-food energy feedstocks such as corn cob and switchgrass, and a downstream biofuel technology to produce biobutanol, a high-performance biofuel that can be delivered through existing gasoline distribution channels.

In May, DuPont announced a joint venture with Danisco to deliver low cost, sustainable cellulosic ethanol technology. In July, the DuPont Danisco Cellulosic Ethanol LLC joint venture announced a partnership with the University of Tennessee to build a pilot and demonstration facility for the cellulosic ethanol technology, groundbreaking scheduled later this month. Pilot production utilizing corn cob and switchgrass is expected to begin in 2009 with commercially viable economics by 2010.

Biobutanol blends can be transported using existing fuel infrastructure, have a higher blend value, provide fuel economy (miles per gallon) similar to unleaded gasoline and can be blended at a minimum of 16 percent concentrations without the need to modify vehicles. DuPont is jointly developing biobutanol with BP in a partnership first announced in 2006.

"We are on track to have a biobutanol pilot facility operational next year with the commercial biotechnology package complete by 2010 at economics comparable to grain ethanol," Ranieri said. "Once we are commercial with biobutanol we intend to combine our technologies to make biobutanol from non-food feedstocks."

DuPont (NYSE: DD) is a science-based products and services company. Founded in 1802, DuPont puts science to work by creating sustainable solutions essential to a better, safer, healthier life for people everywhere. Operating in more than 70 countries, DuPont offers a wide range of innovative products and services for markets including agriculture and food; building and construction; communications; and transportation.

Forward-Looking Statements: This news release contains forward-looking statements based on management's current expectations, estimates and projections. All statements that address expectations or projections about the future, including statements about the company's strategy for growth, product development, market position, expected expenditures and financial results are forward-looking statements. Some of the forward-looking statements may be identified by words like "expects," "anticipates," "plans," "intends," "projects," "indicates," and similar expressions. These statements are not guarantees of future performance and involve a number of risks, uncertainties and assumptions. Many factors, including those discussed more fully elsewhere in this release and in DuPont's filings with the Securities and Exchange Commission, particularly its latest annual report on Form 10-K, as well as others, could cause results to differ materially from those stated. These factors include, but are not limited to changes in the laws, regulations, policies and economic conditions of countries in which the company does business; competitive pressures; successful integration of structural changes, including acquisitions, divestitures and alliances; research and development of new products, including regulatory approval and market acceptance, and seasonality of sales of agricultural products.

Links:

Biofuels fact sheet: http://vocuspr.vocus.com/VocusPR30/Newsroom/MultiQuery.aspx?SiteName=Dupont New&Entity=PRAsset&SF_PRAsset_PRAssetID_EQ=103404&XSL=MediaRoomText&PageTit le=Fact Sheet&IncludeChildren=true&Cache=False

DuPont Danisco Cellulosic Ethanol LLC: http://www.dupontdanisco.com

Pioneer Hi-Bred, a DuPont Company: http://www.pioneer.com/


'/>"/>
SOURCE DuPont
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Childrens Health Care
2. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
3. Pioneer(R) Brand Soybeans From DuPont Deliver Step-Change in Soybean Yields
4. Neogen Acquires Product Line From DuPont Animal Health Solutions
5. DuPont Well Positioned for Long-Term Growth in Agricultural Productivity, Safety and Security, Renewable Energy
6. DuPont Expands Animal Health Solutions Business in Asia
7. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company
8. DuPont Strengthens Commitment to Responsible Science with New Biotech Advisory Panel Members
9. DuPont Partnering with China to Increase Farm Productivity
10. DuPont Reports First Quarter Earnings Growth of Over 20 Percent
11. Research Confirms Better Oil from New DuPont High Oleic Soybean Trait
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of ... health care systems, in terms of costs and resources. However, ... the development of innovative and efficient therapies that demonstrate higher ... types of cancer treatments, a growing number of patients receiving ...
(Date:3/22/2017)... 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), today ... (RGC), U.K. Biobank and GSK to generate genetic sequence data ... The initiative will enable researchers to gain valuable insights to ... wide range of serious and life threatening diseases. ... Genetic evidence ...
(Date:3/22/2017)... , March 22, 2017 Oramed Pharmaceuticals ... www.oramed.com ), a clinical-stage ... drug delivery systems, announced today that Dr. ... deliver a presentation titled, "Oral Insulin for Diabetes ... Cambridge Healthtech Institute,s Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference ...
(Date:3/22/2017)... , March 22, 2017   Boston Biomedical , ... therapeutics designed to target cancer stemness pathways, today announced ... Andrews as Chief Executive Officer, effective April 24, ... Chiang J. Li , M.D., FACP, who has led ... ago. Under his leadership, Boston Biomedical has grown from ...
Breaking Biology Technology:
(Date:3/6/2017)... , March 6, 2017 Mintigo ... technology, today announced Predictive Sales Coach TM , ... actionable sales intelligence into Salesforce. This unique AI ... their sales organizations with deep knowledge of their ... for intelligent engagement. Predictive Sales Coach extends Mintigo,s ...
(Date:3/1/2017)... BEDFORD, Mass. , March 1, 2017  Aware, ... and services, announced that Richard P. Moberg ... Officer and co-President and Chief Financial Officer and Treasurer ... will continue to serve as a member of the ... T. Russell , Aware,s co-Chief Executive Officer and co-President, ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, a ... solutions for public safety, investigation, corrections and monitoring, ... and Reentry. "Too often, too many ... and county jails are trying to tackle this ... and friends and family members. While significant steps are ...
Breaking Biology News(10 mins):